BEST PHARMACEUTICALS FOR CHILDREN ACT

Amendments

Enact (S. 838), S10816, S10844, S10848 [18OC]

Bills and resolutions

Enact (see S. 838), S4416 [7MY]

Memorandums

Approval of Generic Versions of Drugs Without Pediatric Labeling, H10209 [18DE]

———Laurence H. Tribe, E2286-E2288 [13DE]

———Wilmer, Cutler & Pickering (law firm), H8106 [13NO]

Remarks in House

Enact (H.R. 2887), H8094-H8107 [13NO], H8166 [14NO], H8551 [28NO], E2073 [14NO], E2103 [15NO], E2114 [16NO], E2286 [13DE]

Enact (S. 1789), H10200-H10212 [18DE], E2368, E2389 [20DE]

Hazardous substances: recall and suspend use of vaccines containing mercury and certain other chemical substances, H10206 [18DE]

Pharmaceuticals: approval of generic versions of drugs without pediatric labeling relative to exclusive marketing rights agreements, H8551 [28NO], H10209 [18DE], E2286 [13DE]

Remarks in Senate

Enact (S. 838), S4422-S4425 [7MY], S10816-S10819, S10826-S10831 [18OC], S10871-S10873 [23OC]

Enact (S. 1789), S13070 [12DE]

Reports filed

Provisions: Committee on Energy and Commerce (House) (H.R. 2887) (H. Rept. 107-277), H8034 [9NO]

———Committee on Health, Education, Labor, and Pensions (Senate) (S. 838) (S. Rept. 107-79), S10286 [4OC]

Tables

Estimated cost to consumers of exclusivity extensions for certain pediatric drugs, H8102 [13NO]

Texts of

H.R. 2887, provisions, H8094-H8098 [13NO]

S. 838, provisions, S4422-S4424 [7MY]

S. 1789, provisions, S13071-S13076 [12DE], H10200-H10204 [18DE]